about
Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrierTRPC6 in glomerular health and disease: what we know and what we believePodocytesCharacterization of novel VEGF (vascular endothelial growth factor)-C splicing isoforms from mouseQuantitating glomerular endothelial fenestration: an unbiased stereological approach.Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism.Renal Therapeutic Angiogenesis Using a Bioengineered Polymer-Stabilized Vascular Endothelial Growth Factor ConstructThe endoderm indirectly influences morphogenetic movements of the zebrafish head kidney through the posterior cardinal vein and VegfCHypoxia inducible factor-1alpha correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinoma.Inhibition of the VEGF signalling pathway and glomerular disorders.Exogenous vascular endothelial growth factor supplementation can restore the podocyte barrier-forming capacity disrupted by sera of preeclamptic women.The balance of autocrine VEGF-A and VEGF-C determines podocyte survival.Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium.Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro.Lymphangioleiomyoma cells and lymphatic endothelial cells: expression of VEGFR-3 in lymphangioleiomyoma cell clusters.Vascular Endothelial Growth Factor Therapy for the Kidney: Are We There Yet?Sirolimus interacts with pathways essential for podocyte integrity.
P2860
Q24644639-75944752-748D-49DB-B4E0-A2D328BD05CEQ24652809-81F4189E-FA6F-4FC7-B096-51A34DDE3920Q26766118-89EC7490-18E0-40B8-92FA-AB19122A203FQ28588181-47596E7B-462D-4B95-BA5D-E3AE18A6E76CQ35063588-ACD412DC-D84A-42B0-A861-151390914503Q36788592-80851F4A-16FC-42AD-8D79-02DAAB638D86Q36944671-ADF9F2D2-A6DD-4053-9D75-3B3215AF859BQ37141314-9F56BC52-0834-44BF-A154-D428D1CCBCA4Q37148880-CE990725-1230-4748-8E82-BC055D9DFA26Q38284055-9B5E483C-E4FE-48F7-8685-8A511B46C10AQ39341170-593C1A38-9192-4AE7-8F61-601E429EF816Q39787486-776B178C-E00F-4AF8-9707-EA8FC4D12EA2Q39943126-AE9DE09B-CF57-4622-906A-8A4A71E8F360Q42039790-39029FE4-A863-4B82-83A9-B41BABC0C35FQ42861640-A5245329-1FFA-49D1-843F-7A41ED2519C4Q43110449-FEB3E7B6-C7B9-4622-A624-57507919D393Q45151652-330EA3F6-7773-4F9F-BEEF-F850591670C3
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
VEGF-C promotes survival in podocytes.
@en
type
label
VEGF-C promotes survival in podocytes.
@en
prefLabel
VEGF-C promotes survival in podocytes.
@en
P2093
P2860
P1476
VEGF-C promotes survival in podocytes.
@en
P2093
M A Saleem
M S Emmett
P W Mathieson
R R Foster
S C Satchell
S J Harper
P2860
P304
P356
10.1152/AJPRENAL.00431.2005
P577
2006-03-08T00:00:00Z